Efficacy of DLBS1033 in Patients With Acute Ischemic Stroke

Summary

This is a 3-arm, prospective, randomized, double-blind, and controlled clinical study, with 3 months of treatment to evaluate efficacy of DLBS1033 in bleeding profile and clinical outcome in patients with acute ischemic stroke compared with aspirin and clopidogrel, as active controls.

Timeline

Start

2012-05

Primary completion

2013-11

Completion

2013-12

Drugs

Indications